Quva pharma, INC.:1327585 [23-000790] sterile compounded products
Ended Purchase Order Awarded Last action
- Contract number
- 75N90023P00020
- Awardee
-
Quva Pharma, Inc. UEI MUABDCZXMLG4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $60,000
Award facts
- Contract value 100% obligated
- $60,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Sugar Land, TX 77478, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $35,000 | |
| Original award | $25,000 |
Quick answers
Who was awarded contract 75N90023P00020?
75N90023P00020 was awarded to Quva Pharma, Inc. by NIH Clinical Center (National Institutes of Health) on October 24, 2022.
How much is contract 75N90023P00020 worth?
The government has obligated $60,000 on 75N90023P00020.
Was contract 75N90023P00020 competed?
The extent of competition for 75N90023P00020 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award